Eli Lilly is the best of both worlds — a recession-resistant stock with major growth potential
The year ahead is pivotal for Eli Lilly (LLY) as the pharmaceutical giant advances its stellar drug pipeline.
Tfoso
0
63
Traders work beneath monitors displaying Eli Lilly signage on the floor of the New York Stock Exchange.
Michael Nagle | Bloomberg | Getty Images
The year ahead is pivotal for Eli Lilly (LLY) as the pharmaceutical giant looks to advance drugs in its stellar pipeline. Executives detailed reasons for optimism at a major industry gathering this week.
